Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Jefferies Downgrades XPeng to Underperform, Lowers Price Target to $4.2

Jefferies Downgrades XPeng to Underperform, Lowers Price Target to $4.2

Jefferies analyst Johnson Wan downgrades XPeng (NYSE:XPEV) from Hold to Underperform and lowers the price target from $18.6 to $4.2.

November 28, 2022

1 minute read

Jefferies analyst Johnson Wan downgrades XPeng (NYSE:XPEV) from Hold to Underperform and lowers the price target from $18.6 to $4.2.

Goldman Sachs Maintains Neutral on Myovant Sciences, Raises Price Target to $10

July 28, 9:47 AM

Goldman Sachs analyst Madhu Kumar maintains Myovant Sciences (NYSE:MYOV) with a Neutral and raises the price target from $9 to $10.

January 6, 9:46 AM

UBS analyst Peter Grom maintains Constellation Brands (NYSE:STZ) with a Buy and lowers the price target from $281 to $267.

August 17, 4:38 PM

-Reuters

August 9, 3:23 PM

https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=212944#181